Details for 2017730629

Up to date per 02.04.2026

Actions

Title / Product Name

PD-1 BLOCKADE MIT NIVOLUMAB ZUR BEHANDLUNG DES REFRAKTÄREN HODGKIN-LYMPHOMS

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2017730629

EP Publication Number

3464368

E-Number

1582641

Language

PCT Number

US17035521

Publication Date

10.04.2019 A

28.06.2023 B1

Registration Date

28.06.2023

AT Publication Date

15.07.2023

Application Date

01.06.2017

Registration Number

Priorities

02.06.2016

201662344866 P

02.09.2016

201662382839 P

IPC

C07K 16/28 20060101AFI20171208BHEP

Maximum Duration of Protection

01.06.2037

Owner

Bristol-Myers Squibb CompanyRoute 206 and Province Line Road Princeton, NJ 08543US

Seagen Inc.21823 30th Drive S.E. Bothell, WA 98021US

Representative

Patentanwalt Mikšovsky KGBisamberger Straße 192100 KorneuburgAT

Inventor

FARSACI, BenedettoRt. 206&Province Line Road Princeton New Jersey 08543US

JOSEPHSON, Neilc/o Seattle Genetics Inc. 21823 30th Drive SE Bothell Washington 98021US

CAO, Anthony23707 NE 25th Way Sammamish Washington 98074US

HEISER, Ryan1032 116th Ave SE Lake Stevens Washington 98258US

Information about Fees